Alzheimer's drug that slows disease gets backing from FDA advisers

WASHINGTON — A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers Monday, setting the stage for the treatment's expected ... Read more

Bron:

Economy - Voice of America